Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis

Breast Cancer Research and Treatment

Volumn 114, Issue 3, 2009, Pages 423-431

  Habibi, Mehran ^a   Kmieciak, MacIej ^a   Graham, Laura ^a   Morales, Johanna K ^a   Bear, Harry D ^a   Manjili, Masoud H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Breast cancer; Immunotherapy; Interleukin 15 (IL 15); Interleukin 7 (IL 7); Myeloid derived suppressor cells (MDSC); Radiofrequency thermal ablation (RFA)

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOGENICITY; LUNG METASTASIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SUPPRESSOR CELL; TRANSGENIC MOUSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR IMMUNITY;

ANIMALS; ANTINEOPLASTIC AGENTS; CATHETER ABLATION; FEMALE; IMMUNE SYSTEM; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKIN-7; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEOPLASM METASTASIS; RATS;

EID: 61449147270     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0024-3     Document Type: Article

References (38)

1. SS Jeffrey RL Birdwell DM Ikeda BL Daniel KW Nowels FM Dirbas SM Griffey 1999 Radiofrequency ablation of breast cancer: first report of an emerging technology Arch Surg 134 1064 1068
2. G Vlastos HM Verkooijen 2007 Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer The Oncologist 12 1 10
3. A Zerbini M Pilli A Penna G Pelosi C Schianchi A Molinari 2006 Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses Cancer Res 66 1139 1146
4. MH den Brok RP Sutmuller R van der Voort EJ Bennink CG Figdor TJ Ruers 2004 In situ tumor ablation creates an antigen source for the generation of antitumor immunity Cancer Res 64 4024 4029
5. BD Fornage N Sneige MI Ross AN Mirza HM Kuerer BS Edeiken FC Ames LA Newman GV Babiera SE Singletary 2004 Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study Radiology 231 215 224
6. MS Sabel SB Edge 2001 In-situ ablation of breast cancer Breast Dis 12 131 140
7. J Machi RS Bueno LL Wong 2005 Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma World J Surg 29 1364 1373
8. KS Schluns WC Kieper SC Jameson L Lefrancois 2000 Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo Nat Immunol 1 426 432
9. + memory T cell subsets Proc Natl Acad Sci USA 101 5610 5615
10. SM Kaech JT Tan EJ Wherry BT Konieczny CD Surh R Ahmed 2003 Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells Nat Immunol 4 1191 1198
11. KS Schluns L Lefrancois 2003 Cytokine control of memory T-cell development and survival Nat Rev Immunol 3 269 279
12. R Costello F Duffaud 1992 The pleiotropic effects of interleukin 7 and their pathologic and therapeutic implications Eur J Med 1 119 121
13. TA Waldmann 2006 The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design Nat Rev Immunol 6 595 601
14. W Liu AL Putnam Z Xu-Yu GL Szot MR Lee S Zhu PA Gottlieb P Kapranov TR Gingeras B Fazekas de St Groth C Clayberger DM Soper SF Ziegler JA Bluestone 2006 CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 1701 1711
15. MH Manjili H Arnouk KL Knutson M Kmieciak ML Disis JR Subjeck AL Kazim 2006 Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals" Breast Cancer Res Treat 96 233 241
16. M Kmieciak KL Knutson CI Dumur MH Manjili 2007 HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses Eur J Immunol 37 675 685
17. CT Guy MA Webster M Schaller TJ Parsons RD Cardiff WJ Muller 1992 Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Acad Sci USA 89 10578 10582
18. KL Knutson B Almand Y Dang ML Disis 2004 Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice Cancer Res 64 1146 1151
19. Kmieciak M, Morales JK, Morales J, Bolesta E, Grimes M, Manjili MH (2008) Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design. Cancer Immunol Immunother Feb 16 (Epub ahead of print)
20. BA Pulaski S Ostrand-Rosenberg 1998 Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines Cancer Res 58 1486 1493
21. A Worschech M Kmieciak KL Knutson HD Bear AA Szalay E Wang FM Marincola MH Manjili 2008 Signatures associated with rejection or recurrence in HER-2/neu positive mammary tumors Cancer Res 68 7 2436 2446
22. N Takeuchi S Hiraoka XY Zhou M Nagafuku S Ono T Tsujimura M Nakazawa Y Yura T Hamaoka H Fujiwara 2004 Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice Cancer Res 64 7588 7595
23. KL Knutson H Lu B Stone JM Reiman MD Behrens CM Prosperi EA Gad A Smorlesi ML Disis 2006 Immunoediting of cancers may lead to epithelial to mesenchymal transition J Immunol 177 1526 1533
24. RF Le Veen 1997 Laser hypertermia and radiofrequency ablation of hepatic lesions Semin Intervent Radiol 14 313 324
25. RA Lencioni HP Allgaier D Cioni 2003 Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection Radiology 228 235 240
26. J Hansler D Neureiter D Strobel 2002 Cellular and vascular reactions in the liver to radio-frequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs Eur Surg Res 34 357 363
27. LB Riley A Maggitti M Habibi DC Desai 2004 A new approach to paracrine-based immunotherapy using radiofrequency ablated tissue with fluorescein as a surrogate marker Ann Surg Oncol 11 Supplement 2 S90
28. A Rughetti H Rahimi P Rossi L Frati M Nuti A Gaspari FM Danza L Ercoli 2003 Modulation of blood circulating immune cells by radiofrequency tumor ablation J Exp Clin Cancer Res 22 4 Suppl 247 250
29. BK Park H Zhang Q Zeng J Dai ET Keller T Giordano K Gu V Shah L Pei RJ Zarbo L McCauley S Shi S Chen CY Wang 2007 NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF Nat Med 13 62 69
30. G Parmiani C Castelli L Pilla M Santinami MP Colombo L Rivoltini 2007 Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients Ann Oncol: Off J Eur Soc Med Oncol/ESMO 18 226 232
31. P Filipazzi R Valenti V Huber L Pilla P Canese M Iero C Castelli L Mariani G Parmiani L Rivoltini 2007 Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine J Clin Oncol 25 18 2546 2553
32. S Dai D Wei Z Wu X Zhou X Wei H Huang G Li 2008 Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer Mol Ther 16 4 782 790
33. L Bracci F Moschella P Sestili V La Sorsa M Valentini I Canini S Baccarini S Maccari C Ramoni F Belardelli E Proietti 2007 Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration Clin Cancer Res 13 2 Pt 1 644 653
34. N Leonhartsberger R Ramoner T Putz H Gander A Rahm C Falkensammer G Bartsch M Thurnher 2007 Antigen-independent immune responses after dendritic cell vaccination Cancer Immunol Immunother 56 897 903
35. LX Wang R Li G Yang M Lim A O'Hara Y Chu BA Fox NP Restifo WJ Urba HM Hu 2005 Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing Cancer Res 65 10569 10577
36. F Melchionda TJ Fry MJ Milliron MA McKirdy Y Tagaya CL Mackall 2005 Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool J Clin Invest 115 1177 1187
37. MH den Brok RP Sutmuller S Nierkens EJ Bennink C Frielink LW Toonen OC Boerman CG Figdor TJ Ruers GJ Adema 2006 Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity Br J Cancer 95 7 896 905
38. MH den Brok RP Sutmuller S Nierkens EJ Bennink LW Toonen CG Figdor TJ Ruers GJ Adema 2006 Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine Cancer Res 66 14 7285 7292